— Know what they know.
Not Investment Advice
Also trades as: XYLO (NASDAQ) · $vol 0M

MDGS NASDAQ

Xylo Technologies Ltd.
1W: +19.1% 1M: -22.8% 3M: -37.9% 1Y: -70.8% 3Y: -91.5% 5Y: -94.9%
$2.36
Last traded 2024-05-13 — delisted
NASDAQ · Healthcare · Medical - Devices · $178.9M mcap · 26M float · 0.052% daily turnover

Cash Flow Trends

Operating Cash Flow
-$6M -10.4% ▼
Capital Expenditures
$2M -2260.8% ▼
5Y CAGR: +175.5%
Free Cash Flow
-$8M -39.5% ▼
Dividends Paid
$0 +100.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$11M -170.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$14M-$7M$4M-$10M-$22M
Depreciation & Amort.$75K$167K$320K$3M$4M
Stock-Based Comp.$259K$1M$2M$787K$1M
Change in Working Capital$1M-$276K$118K-$1M$668K
Other Non-Cash Items$10M$537K$582K$1M$2M
Operating Cash Flow-$3M-$6M-$5M-$6M-$6M
— Investing Activities —
Capital Expenditures-$62K-$324K-$141K-$74K-$2M
Acquisitions (Net)-$4M-$1M-$8M-$2M-$5M
Investment Purchases-$4M-$2M-$234K-$7M-$83K
Investment Sales$8M$3M$2M$453K$6M
Other Investing-$4M-$1M-$6M$4M-$469K
Investing Cash Flow-$4M-$2M-$12M-$4M-$1M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0-$23M$0$0$0
Dividends Paid$0$0$0-$2M$0
Other Financing$3M$23M$19M$7M-$3M
Financing Cash Flow$3M$23M$19M$5M-$3M
Net Change in Cash-$4M$15M$2M-$4M-$11M
Cash End of Period$7M$22M$24M$20M$9M
Free Cash Flow-$3M-$6M-$5M-$6M-$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms